Evolent Health, Inc.
Data quality: 100%
EVH
NYSE
Services
Engineering & Management Services
$2.33
▼
$0.11
(-4.51%)
Mkt Cap: 269.05 M
Price
$2.41
Mkt Cap
269.05 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Revenue grew 19.90% annually over 5 years — strong growth
Generating 38.84 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 46.46%
Growth
Revenue Growth (5Y)
19.90%
Above sector avg (3.99%)
Revenue (1Y)-26.56%
Earnings (1Y)N/A
FCF Growth (3Y)-47.81%
Quality
Return on Equity
-61.50%
Below sector avg (-15.95%)
ROIC-15.79%
Net Margin-28.49%
Op. Margin-21.86%
Safety
Debt / Equity
1.26
Above sector avg (0.39)
Current Ratio1.33
Interest Coverage-7.14
Valuation
PE (TTM|2027)
-0.50 | 5.46
Above sector avg (-1.17)
P/B Ratio0.32
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (502 peers)
Peer Comparison
vs Services sector median (502 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.5 | -1.2 |
| P/B | 0.3 | 1.4 |
| ROE % | -61.5 | -16.0 |
| Net Margin % | -28.5 | -19.4 |
| Rev Growth 5Y % | 19.9 | 4.0 |
| D/E | 1.3 | 0.4 |
Analyst Price Target
14 analysts
Buy
Current
$2.33
Target
$5.18
$3.00
$5.00
$8.00
Forecast
Forward P/E
5.27
Forward EPS
$0.44
EPS Growth (est.)
+157.4%
Est. Revenue
2.88 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.44
$0.30 – $0.73
|
2.88 B | 11 |
| FY2026 |
$0.17
$0.10 – $0.35
|
2.49 B | 10 |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 |
-$0.02
-$0.05 – $0.02
|
608.19 M | 8 |
| 2026 Q1 |
-$0.05
-$0.09 – $0.01
|
534.04 M | 10 |
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q42025 | $0.05 | $0.08 | +62.7% |
| Q32025 | $0.10 | $0.05 | -51.2% |
| Q22025 | $0.08 | -$0.10 | -223.3% |
| Q12025 | $0.10 | $0.06 | -37.7% |
ETFs Holding This Stock
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -26.56% | Revenue Growth (3Y) | 83.69% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19.90% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.88 B | Net Income (TTM) | -534.51 M |
| ROE | -61.50% | ROA | -21.75% |
| Gross Margin | N/A | Operating Margin | -21.86% |
| Net Margin | -28.49% | Free Cash Flow (TTM) | 38.84 M |
| ROIC | -15.79% | FCF Growth (3Y) | -47.81% |
| Safety | |||
| Debt / Equity | 1.26 | Current Ratio | 1.33 |
| Interest Coverage | -7.14 | Asset Turnover | 0.76 |
| Working Capital | 140.17 M | Tangible Book Value | -856.84 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.50 | Forward P/E | N/A |
| P/B Ratio | 0.32 | P/S Ratio | 0.14 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 14.44% | ||
| Market Cap | 269.05 M | Enterprise Value | 1.21 B |
| Per Share | |||
| EPS (Diluted TTM) | -5.07 | Revenue / Share | 16.81 |
| FCF / Share | 0.35 | OCF / Share | 0.35 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | -7.27% |
| SBC-Adj. FCF | -12.92 M | Growth Momentum | -46.46 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.88 B | 2.55 B | 556.06 M | 382.43 M | 907.96 M |
| Net Income | -534.51 M | -61.62 M | -113.04 M | -19.16 M | -9.81 M |
| EPS (Diluted) | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -410.14 M | -40.49 M | -71.21 M | 3.64 M | -42.41 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | 15.50 M |
| SG&A Expenses | 303.87 M | 263.05 M | 358.11 M | 269.27 M | 219.50 M |
| D&A | 115.85 M | 118.37 M | 123.42 M | 67.20 M | 60.04 M |
| Interest Expense | 57.47 M | 24.72 M | 54.21 M | 15.57 M | 25.43 M |
| Income Tax | -126,000.0 | -1.41 M | -89.37 M | -43.38 M | 483,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.90 B | 2.54 B | 2.68 B | 1.82 B | 1.42 B |
| Total Liabilities | 1.48 B | 1.35 B | 1.43 B | 957.88 M | 725.83 M |
| Shareholders' Equity | 415.19 M | 1.00 B | 1.07 B | 859.42 M | 693.63 M |
| Total Debt | 970.54 M | 661.99 M | 597.05 M | 412.99 M | 215.68 M |
| Cash & Equivalents | 151.86 M | 104.20 M | 192.83 M | 188.20 M | 266.28 M |
| Current Assets | 506.37 M | 607.12 M | 683.67 M | 478.05 M | 523.96 M |
| Current Liabilities | 385.26 M | 715.50 M | 674.24 M | 433.44 M | 445.49 M |
{"event":"ticker_viewed","properties":{"ticker":"EVH","listing_kind":"stock","pathname":"/stocks/evh","exchange":"NYSE","country":"US"}}
